These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 17272749)
1. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Mor A; Planer D; Luboshits G; Afek A; Metzger S; Chajek-Shaul T; Keren G; George J Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):893-900. PubMed ID: 17272749 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956 [TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice. Feng J; Zhang Z; Kong W; Liu B; Xu Q; Wang X Cardiovasc Res; 2009 Oct; 84(1):155-63. PubMed ID: 19502284 [TBL] [Abstract][Full Text] [Related]
4. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Mor A; Luboshits G; Planer D; Keren G; George J Eur Heart J; 2006 Nov; 27(21):2530-7. PubMed ID: 16954132 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease. Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422 [TBL] [Abstract][Full Text] [Related]
6. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4 Wan Q; Liu Z; Yang M; Wu J Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887 [TBL] [Abstract][Full Text] [Related]
7. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383 [TBL] [Abstract][Full Text] [Related]
8. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Xie JJ; Wang J; Tang TT; Chen J; Gao XL; Yuan J; Zhou ZH; Liao MY; Yao R; Yu X; Wang D; Cheng Y; Liao YH; Cheng X Cytokine; 2010 Feb; 49(2):185-93. PubMed ID: 19836260 [TBL] [Abstract][Full Text] [Related]
9. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis. Zhang Y; Wang HB; Chi LJ; Wang WZ Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574 [TBL] [Abstract][Full Text] [Related]
10. Role of regulatory T cells in atheroprotective effects of granulocyte colony-stimulating factor. Uchiyama R; Hasegawa H; Kameda Y; Ueda K; Kobayashi Y; Komuro I; Takano H J Mol Cell Cardiol; 2012 May; 52(5):1038-47. PubMed ID: 22285481 [TBL] [Abstract][Full Text] [Related]
11. Bacterial DNA confers neuroprotection after optic nerve injury by suppressing CD4+CD25+ regulatory T-cell activity. Johnson TV; Camras CB; Kipnis J Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3441-9. PubMed ID: 17652711 [TBL] [Abstract][Full Text] [Related]
12. [Influence of high mobility group box-1 protein on the correlation between regulatory T cells and CD4+ CD25- T cells of spleen in mice]. Zhang Y; Yao YM; Yu Y; Wu Y; Sheng ZY Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):217-20. PubMed ID: 18683721 [TBL] [Abstract][Full Text] [Related]
13. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media. Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297 [TBL] [Abstract][Full Text] [Related]
14. Changes in CD4 Xue-Mei L; Jie C; Xuan D; Xiao-Xing L; Chun-Lin H; Yu-Jie L Exp Biol Med (Maywood); 2017 May; 242(9):918-925. PubMed ID: 28114815 [TBL] [Abstract][Full Text] [Related]
15. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Heller EA; Liu E; Tager AM; Yuan Q; Lin AY; Ahluwalia N; Jones K; Koehn SL; Lok VM; Aikawa E; Moore KJ; Luster AD; Gerszten RE Circulation; 2006 May; 113(19):2301-12. PubMed ID: 16682613 [TBL] [Abstract][Full Text] [Related]
16. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts. Giorgini A; Noble A J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039 [TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655 [TBL] [Abstract][Full Text] [Related]
18. Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice. Afek A; Kogan E; Maysel-Auslender S; Mor A; Regev E; Rubinstein A; Keren G; George J Microvasc Res; 2009 May; 77(3):364-9. PubMed ID: 19323972 [TBL] [Abstract][Full Text] [Related]
19. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027 [TBL] [Abstract][Full Text] [Related]
20. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells. Parietti V; Monneaux F; Décossas M; Muller S Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]